Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
vonapanitase (8 trials)
Arteriovenous Fistula (Phase 3)
Fistula (Phase 3)
Kidney Diseases (Phase 3)
Peripheral Arterial Disease (Phase 1)
Renal Insufficiency, Chronic (Phase 3)
Trials (8 total)
Trial APIs (1 total)